Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Cannabinoids: potential anticancer agents.

Guzmán M.

Nat Rev Cancer. 2003 Oct;3(10):745-55. Review.

PMID:
14570037
2.

[Cannabinoids--signal transduction and mode of action].

Rukwied R, Gauter B, Schley M, Konrad C.

Schmerz. 2005 Nov;19(6):528-34. Review. German.

PMID:
15549420
3.

Cannabis-derived substances in cancer therapy--an emerging anti-inflammatory role for the cannabinoids.

Liu WM, Fowler DW, Dalgleish AG.

Curr Clin Pharmacol. 2010 Nov;5(4):281-7. Review.

PMID:
20925645
4.

Cannabinoids and gliomas.

Velasco G, Carracedo A, Blázquez C, Lorente M, Aguado T, Haro A, Sánchez C, Galve-Roperh I, Guzmán M.

Mol Neurobiol. 2007 Aug;36(1):60-7. Epub 2007 Jun 28. Review.

PMID:
17952650
5.

Cannabinoids and cancer: potential for colorectal cancer therapy.

Patsos HA, Hicks DJ, Greenhough A, Williams AC, Paraskeva C.

Biochem Soc Trans. 2005 Aug;33(Pt 4):712-4. Review.

PMID:
16042581
6.

[Different views on the association between cannabinoids and cancer].

Vidinský B, Gál P, Mojzis J.

Cas Lek Cesk. 2006;145(6):453-7; discussion 458-9. Review. Slovak.

PMID:
16835997
7.

[Therapeutic applications and biomedical effects of cannabinoids; pharmacological starting points].

Killestein J, Nelemans SA.

Ned Tijdschr Geneeskd. 1997 Aug 30;141(35):1689-93. Review. Dutch.

PMID:
9543785
8.
9.

Cannabinoids:their role in pain and palliation.

McCarberg BH.

J Pain Palliat Care Pharmacother. 2007;21(3):19-28. Review.

PMID:
18032352
10.

Cannabinoids: a new hope for breast cancer therapy?

Caffarel MM, Andradas C, Pérez-Gómez E, Guzmán M, Sánchez C.

Cancer Treat Rev. 2012 Nov;38(7):911-8. doi: 10.1016/j.ctrv.2012.06.005. Epub 2012 Jul 7. Review.

PMID:
22776349
11.

Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?

Oesch S, Gertsch J.

J Pharm Pharmacol. 2009 Jul;61(7):839-53. doi: 10.1211/jpp/61.07.0002. Review.

PMID:
19589225
12.

Effects on cell viability.

Guzmán M.

Handb Exp Pharmacol. 2005;(168):627-42. Review.

PMID:
16596790
13.

Cannabinoid-associated cell death mechanisms in tumor models (review).

Calvaruso G, Pellerito O, Notaro A, Giuliano M.

Int J Oncol. 2012 Aug;41(2):407-13. doi: 10.3892/ijo.2012.1476. Epub 2012 May 14. Review.

PMID:
22614735
14.

Human studies of cannabinoids and medicinal cannabis.

Robson P.

Handb Exp Pharmacol. 2005;(168):719-56. Review.

PMID:
16596794
15.

The use of cannabinoids as anticancer agents.

Velasco G, Hernández-Tiedra S, Dávila D, Lorente M.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:259-66. doi: 10.1016/j.pnpbp.2015.05.010. Epub 2015 Jun 10. Review.

16.

Cannabinoids and cancer: pros and cons of an antitumour strategy.

Bifulco M, Laezza C, Pisanti S, Gazzerro P.

Br J Pharmacol. 2006 May;148(2):123-35. Review.

17.

Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain.

Martin BR, Wiley JL.

J Support Oncol. 2004 Jul-Aug;2(4):305-14; discussion 314-6. Review.

PMID:
15357514
18.

Hypothesis: cannabinoid therapy for the treatment of gliomas?

Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Guzmán M.

Neuropharmacology. 2004 Sep;47(3):315-23. Review.

PMID:
15275820
19.

The intersection between cannabis and cancer in the United States.

Bowles DW, O'Bryant CL, Camidge DR, Jimeno A.

Crit Rev Oncol Hematol. 2012 Jul;83(1):1-10. doi: 10.1016/j.critrevonc.2011.09.008. Epub 2011 Oct 21. Review.

PMID:
22019199
20.

[Cannabinoids and the immune system. Of men, mice and cells].

Kraft B, Kress HG.

Schmerz. 2004 Jun;18(3):203-10. Review. German.

PMID:
15221424

Supplemental Content

Support Center